🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Bayer sells more crop science assets to BASF for 1.7 billion euros

Published 26/04/2018, 17:22
© Reuters. Bayer CEO Baumann is posing in front of the drugmaker's logo following the annual results news conference in Leverkusen
BASFN
-
BAYGN
-
MON
-

FRANKFURT (Reuters) - Bayer AG (DE:BAYGn) said it had agreed to sell more crop science businesses to BASF (DE:BASFn) in a deal that fulfils undertakings to the European Union and other regulators as part of its takeover of Monsanto (N:MON).

The package, being sold for up to 1.7 billion euros (1.5 billion pounds), includes its global vegetable seeds business, certain seed treatments and digital farming activities with total sales of 745 million euros in 2017.

"With this move, we are implementing the corresponding undertakings made to the European Commission and other regulatory authorities to allow the successful closing of the Monsanto transaction," Werner Baumann, Chairman of the Board of Management of Bayer AG, said in a statement.

The sale is subject to the closing of the Monsanto takeover. It includes the transfer of 2,500 staff, around 150 of them in Germany. BASF has committed to keep all permanent positions for at least three years after the deal closes.

© Reuters. Bayer CEO Baumann is posing in front of the drugmaker's logo following the annual results news conference in Leverkusen

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.